Healthcare Sector Stocks
The Healthcare sector has a total of 1065 stocks, with a combined market cap of $8.18 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 40.72.
Market Cap
8.18T
Revenue
4.59T
Profits
200.92B
PE Ratio
40.72
Profit Margin
4.38%
Dividend Yield
0.43%
1065 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 893.77B | -0.44% | 1,482,157 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 547.14B | -1.52% | 4,458,290 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 372.44B | 0.01% | 3,202,587 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 355.54B | -1.90% | 6,425,314 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 287.29B | -1.62% | 1,062,537 | 60.44B |
| 6 | NVS | Novartis AG | 284.82B | -1.00% | 672,554 | 56.58B |
| 7 | MRK | Merck & Co., Inc. | 275.43B | -1.67% | 5,565,139 | 65.77B |
| 8 | NVO | Novo Nordisk A/S | 207.87B | -2.49% | 13,095,384 | 50.57B |
| 9 | AMGN | Amgen Inc. | 176.51B | -2.73% | 1,471,571 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 162.84B | -2.24% | 1,423,126 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 161.07B | -1.76% | 3,858,979 | 29.74B |
| 12 | ISRG | Intuitive Surgical, Inc. | 149.08B | -1.66% | 1,687,234 | 10.58B |
| 13 | ABT | Abbott Laboratories | 147.17B | -0.48% | 9,498,349 | 45.13B |
| 14 | PFE | Pfizer Inc. | 144.14B | -1.79% | 27,376,342 | 63.32B |
| 15 | CVS | CVS Health Corporation | 122.80B | -0.94% | 5,494,067 | 405.62B |
| 16 | SYK | Stryker Corporation | 117.96B | 0.71% | 2,486,150 | 25.27B |
| 17 | BMY | Bristol-Myers Squibb Company | 116.13B | 0.18% | 6,595,820 | 48.48B |
| 18 | DHR | Danaher Corporation | 114.09B | -2.03% | 2,679,704 | 24.78B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 110.62B | -3.23% | 690,664 | 12.22B |
| 20 | SNY | Sanofi | 102.61B | -0.09% | 2,187,258 | 54.60B |
| 21 | GSK | GSK plc | 100.77B | -2.55% | 3,022,845 | 43.29B |
| 22 | MDT | Medtronic plc | 98.04B | -0.79% | 6,098,571 | 35.48B |
| 23 | HCA | HCA Healthcare, Inc. | 94.19B | -1.87% | 678,610 | 76.39B |
| 24 | MCK | McKesson Corporation | 91.68B | 2.07% | 1,026,872 | 403.43B |
| 25 | ELV | Elevance Health, Inc. | 85.82B | -0.38% | 879,434 | 200.42B |
| 26 | BSX | Boston Scientific Corporation | 78.30B | -1.62% | 10,355,771 | 20.61B |
| 27 | CI | The Cigna Group | 75.89B | -2.73% | 1,448,989 | 277.89B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 71.06B | -2.03% | 473,218 | 14.92B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 52.51B | -0.06% | 2,341,517 | 28.34B |
| 30 | ARGX | argenx SE | 50.39B | -1.88% | 235,853 | 4.74B |
| 31 | COR | Cencora, Inc. | 50.38B | -0.83% | 1,466,739 | 328.68B |
| 32 | MDLN | Medline Inc. | 48.07B | -5.94% | 5,322,191 | 29.14B |
| 33 | EW | Edwards Lifesciences Corporation | 46.94B | 0.22% | 2,506,044 | 6.30B |
| 34 | CAH | Cardinal Health, Inc. | 45.89B | 0.79% | 2,053,458 | 250.74B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 41.82B | -0.50% | 371,733 | 4.45B |
| 36 | TEVA | Teva Pharmaceutical Industries Limited | 40.06B | -2.56% | 5,314,402 | 17.35B |
| 37 | BDX | Becton, Dickinson and Company | 39.44B | -0.92% | 1,474,002 | 22.23B |
| 38 | HLN | Haleon plc | 39.40B | 0.56% | 7,707,049 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.63B | -1.39% | 560,632 | 4.29B |
| 40 | HUM | Humana Inc. | 36.70B | 1.43% | 1,278,337 | 137.20B |
| 41 | ONC | BeOne Medicines AG | 32.74B | -3.32% | 224,987 | 5.70B |
| 42 | WAT | Waters Corporation | 32.56B | -0.47% | 473,218 | 3.77B |
| 43 | A | Agilent Technologies, Inc. | 31.59B | -1.29% | 823,207 | 7.07B |
| 44 | ZTS | Zoetis Inc. | 31.04B | -1.89% | 5,847,829 | 9.53B |
| 45 | ALC | Alcon Inc. | 30.92B | -0.41% | 1,653,400 | 10.63B |
| 46 | RVMD | Revolution Medicines, Inc. | 30.84B | -2.94% | 1,521,822 | - |
| 47 | RPRX | Royalty Pharma plc | 30.33B | -1.35% | 2,626,985 | 2.44B |
| 48 | RMD | ResMed Inc. | 29.39B | 0.09% | 676,611 | 5.54B |
| 49 | CNC | Centene Corporation | 28.66B | -1.12% | 2,979,844 | 178.33B |
| 50 | IQV | IQVIA Holdings Inc. | 28.50B | 0.05% | 967,910 | 16.63B |
| 51 | BIIB | Biogen Inc. | 28.48B | 0.81% | 797,519 | 9.94B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 27.74B | -2.68% | 2,676,459 | 20.98B |
| 53 | NTRA | Natera, Inc. | 27.02B | -4.17% | 1,666,299 | 2.50B |
| 54 | VEEV | Veeva Systems Inc. | 25.96B | 1.79% | 1,458,077 | 3.20B |
| 55 | PHG | Koninklijke Philips N.V. | 24.51B | -0.98% | 1,033,811 | 20.34B |
| 56 | UTHR | United Therapeutics Corporation | 24.10B | -1.40% | 196,040 | 3.17B |
| 57 | INSM | Insmed Incorporated | 23.81B | -4.98% | 2,486,414 | 819.56M |
| 58 | DXCM | DexCom, Inc. | 23.68B | 6.14% | 7,356,992 | 4.82B |
| 59 | BNTX | BioNTech SE | 22.67B | -2.53% | 591,702 | 3.23B |
| 60 | ILMN | Illumina, Inc. | 21.66B | -0.07% | 1,154,525 | 4.39B |
| 61 | WST | West Pharmaceutical Services, Inc. | 21.48B | 1.27% | 406,928 | 3.22B |
| 62 | ROIV | Roivant Sciences Ltd. | 21.13B | 0.10% | 3,795,940 | 13.31M |
| 63 | MTD | Mettler-Toledo International Inc. | 20.95B | -0.48% | 143,352 | 4.09B |
| 64 | STE | STERIS plc | 20.81B | -1.77% | 664,496 | 5.94B |
| 65 | DGX | Quest Diagnostics Incorporated | 20.70B | -0.50% | 382,694 | 11.28B |
| 66 | LH | Labcorp Holdings Inc. | 20.65B | -0.84% | 351,967 | 14.14B |
| 67 | MRNA | Moderna, Inc. | 19.37B | -2.42% | 5,268,694 | 2.23B |
| 68 | VTRS | Viatris Inc. | 19.26B | -4.17% | 5,795,080 | 14.56B |
| 69 | INCY | Incyte Corporation | 19.13B | -1.93% | 1,065,049 | 5.36B |
| 70 | THC | Tenet Healthcare Corporation | 16.78B | -1.86% | 1,095,678 | 21.46B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 16.24B | 1.55% | 1,621,347 | 8.41B |
| 72 | GMAB | Genmab A/S | 16.20B | -1.41% | 1,117,595 | 3.90B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 15.93B | -0.41% | 954,226 | 3.10B |
| 74 | ASND | Ascendis Pharma A/S | 15.00B | -1.64% | 330,422 | 998.25M |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 14.31B | -1.27% | 890,775 | 4.44B |
| 76 | RGC | Regencell Bioscience Holdings Limited | 14.26B | 7.17% | 114,283 | - |
| 77 | SMMT | Summit Therapeutics Inc. | 13.11B | -6.89% | 1,807,213 | - |
| 78 | BBIO | BridgeBio Pharma, Inc. | 13.07B | -4.22% | 1,641,468 | 579.96M |
| 79 | SOLV | Solventum Corporation | 12.91B | 0.20% | 1,095,112 | 8.26B |
| 80 | DVA | DaVita Inc. | 12.73B | 2.97% | 332,657 | 13.84B |
| 81 | SNN | Smith & Nephew plc | 12.71B | -0.44% | 647,889 | 6.16B |
| 82 | PEN | Penumbra, Inc. | 12.68B | -0.21% | 331,122 | 1.45B |
| 83 | GH | Guardant Health, Inc. | 12.64B | -3.39% | 1,257,403 | 1.08B |
| 84 | EXEL | Exelixis, Inc. | 12.63B | -1.70% | 1,286,533 | 2.38B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.19B | -2.55% | 1,196,047 | 1.06B |
| 86 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.12B | -2.61% | 140,350 | 1.13B |
| 87 | BTSG | BrightSpring Health Services, Inc. | 11.98B | -0.26% | 1,828,325 | 13.65B |
| 88 | MEDP | Medpace Holdings, Inc. | 11.92B | -0.42% | 205,606 | 2.68B |
| 89 | AXSM | Axsome Therapeutics, Inc. | 11.70B | -2.12% | 342,406 | 708.24M |
| 90 | RDY | Dr. Reddy's Laboratories Limited | 11.64B | 0.93% | 1,715,374 | 3.58B |
| 91 | COO | The Cooper Companies, Inc. | 11.63B | -1.26% | 1,352,148 | 4.15B |
| 92 | FMS | Fresenius Medical Care AG | 11.60B | 0.88% | 569,024 | 22.32B |
| 93 | ALGN | Align Technology, Inc. | 11.29B | -1.83% | 561,655 | 4.10B |
| 94 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.82B | -3.63% | 1,047,479 | 622.01M |
| 95 | EHC | Encompass Health Corporation | 10.60B | -0.37% | 420,058 | 6.07B |
| 96 | RVTY | Revvity, Inc. | 10.53B | -2.09% | 645,433 | 2.90B |
| 97 | GMED | Globus Medical, Inc. | 10.39B | -0.89% | 663,854 | 3.10B |
| 98 | ENSG | The Ensign Group, Inc. | 10.35B | -0.39% | 317,490 | 5.27B |
| 99 | PODD | Insulet Corporation | 10.24B | -0.61% | 801,469 | 2.90B |
| 100 | UHS | Universal Health Services, Inc. | 10.18B | -1.49% | 617,252 | 17.76B |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 10.02B | -2.57% | 1,400,963 | 3.24B |
| 102 | ELAN | Elanco Animal Health Incorporated | 9.99B | -7.58% | 5,580,965 | 4.89B |
| 103 | MOH | Molina Healthcare, Inc. | 9.65B | -0.87% | 490,396 | 43.10B |
| 104 | ABVX | ABIVAX Société Anonyme | 9.57B | -4.83% | 830,779 | 5.37M |
| 105 | PRAX | Praxis Precision Medicines, Inc. | 9.56B | -0.80% | 157,755 | 7.46M |
| 106 | CYTK | Cytokinetics, Incorporated | 9.44B | -3.54% | 1,235,333 | 105.82M |
| 107 | MASI | Masimo Corporation | 9.35B | 0.07% | 433,071 | 1.56B |
| 108 | KRYS | Krystal Biotech, Inc. | 9.09B | -2.47% | 182,714 | 417.30M |
| 109 | BAX | Baxter International Inc. | 8.94B | -2.67% | 3,361,301 | 11.32B |
| 110 | ICLR | ICON Public Limited Company | 8.86B | -0.89% | 495,281 | 8.10B |
| 111 | GKOS | Glaukos Corporation | 8.43B | 1.05% | 612,635 | 551.35M |
| 112 | HSIC | Henry Schein, Inc. | 8.35B | 0.90% | 1,894,019 | 13.38B |
| 113 | IBRX | ImmunityBio, Inc. | 8.31B | -2.64% | 8,919,074 | 140.98M |
| 114 | NUVL | Nuvalent, Inc. | 8.11B | -1.67% | 551,520 | - |
| 115 | HALO | Halozyme Therapeutics, Inc. | 7.99B | -2.72% | 1,324,720 | 1.51B |
| 116 | TEM | Tempus AI, Inc. | 7.95B | -2.64% | 4,823,629 | 1.36B |
| 117 | PCVX | Vaxcyte, Inc. | 7.63B | -1.25% | 875,431 | - |
| 118 | ATR | AptarGroup, Inc. | 7.35B | -2.42% | 286,438 | 3.87B |
| 119 | CRL | Charles River Laboratories International, Inc. | 7.28B | -5.07% | 779,057 | 4.03B |
| 120 | HQY | HealthEquity, Inc. | 6.94B | -0.22% | 600,677 | 1.31B |
| 121 | OSCR | Oscar Health, Inc. | 6.93B | -0.56% | 5,968,515 | 13.30B |
| 122 | QGEN | Qiagen N.V. | 6.85B | -0.56% | 1,305,827 | 2.10B |
| 123 | TECH | Bio-Techne Corporation | 6.80B | -2.97% | 3,132,028 | 1.21B |
| 124 | KYMR | Kymera Therapeutics, Inc. | 6.77B | -2.58% | 285,821 | 51.48M |
| 125 | CELC | Celcuity Inc. | 6.66B | 2.27% | 949,056 | - |
| 126 | BIO | Bio-Rad Laboratories, Inc. | 6.62B | 0.44% | 233,707 | 2.59B |
| 127 | PTGX | Protagonist Therapeutics, Inc. | 6.60B | -2.70% | 196,788 | 74.06M |
| 128 | GRFS | Grifols, S.A. | 6.57B | -1.54% | 420,543 | 8.58B |
| 129 | BRKR | Bruker Corporation | 6.52B | -3.03% | 1,842,649 | 3.46B |
| 130 | SYRE | Spyre Therapeutics, Inc. | 6.47B | -1.45% | 618,176 | - |
| 131 | MIRM | Mirum Pharmaceuticals, Inc. | 6.29B | -7.34% | 789,634 | 569.61M |
| 132 | ALKS | Alkermes plc | 6.26B | -2.03% | 727,921 | 1.56B |
| 133 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.20B | -3.43% | 344,508 | 217.17M |
| 134 | LNTH | Lantheus Holdings, Inc. | 6.13B | -2.56% | 567,377 | 1.55B |
| 135 | CNTA | Centessa Pharmaceuticals plc | 6.13B | -0.01% | 362,962 | 15.00M |
| 136 | APGE | Apogee Therapeutics, Inc. | 6.11B | -2.79% | 519,171 | - |
| 137 | CORT | Corcept Therapeutics Incorporated | 6.08B | -2.85% | 579,617 | 769.10M |
| 138 | PTCT | PTC Therapeutics, Inc. | 5.99B | -0.74% | 411,510 | 827.11M |
| 139 | SRRK | Scholar Rock Holding Corporation | 5.98B | -2.61% | 835,585 | - |
| 140 | PACS | PACS Group, Inc. | 5.97B | -4.87% | 510,969 | 5.43B |
| 141 | CGON | CG Oncology, Inc. | 5.94B | -3.19% | 810,716 | 5.07M |
| 142 | RGEN | Repligen Corporation | 5.83B | -0.06% | 1,730,042 | 763.34M |
| 143 | TFX | Teleflex Incorporated | 5.77B | 0.06% | 360,316 | 2.13B |
| 144 | HIMS | Hims & Hers Health, Inc. | 5.77B | 2.76% | 15,771,425 | 2.37B |
| 145 | BLCO | Bausch + Lomb Corporation | 5.74B | -1.04% | 282,418 | 5.21B |
| 146 | CHE | Chemed Corporation | 5.73B | 1.66% | 181,507 | 2.54B |
| 147 | IMVT | Immunovant, Inc. | 5.63B | -4.52% | 755,327 | - |
| 148 | BLTE | Belite Bio, Inc | 5.61B | -4.89% | 223,920 | - |
| 149 | TGTX | TG Therapeutics, Inc. | 5.61B | -2.95% | 1,220,529 | 700.35M |
| 150 | COGT | Cogent Biosciences, Inc. | 5.60B | -4.21% | 1,190,975 | - |
| 151 | XENE | Xenon Pharmaceuticals Inc. | 5.27B | -2.59% | 366,839 | 7.50M |
| 152 | APLS | Apellis Pharmaceuticals, Inc. | 5.25B | - | - | 1.11B |
| 153 | AVTR | Avantor, Inc. | 5.22B | -3.78% | 4,860,175 | 6.55B |
| 154 | LQDA | Liquidia Corporation | 5.08B | -3.73% | 1,535,599 | 288.07M |
| 155 | LEGN | Legend Biotech Corporation | 5.04B | -4.79% | 1,344,425 | 1.14B |
| 156 | STVN | Stevanato Group S.p.A. | 4.82B | -1.95% | 243,791 | 1.39B |
| 157 | CRSP | CRISPR Therapeutics AG | 4.70B | -3.45% | 1,505,040 | 4.10M |
| 158 | DNTH | Dianthus Therapeutics, Inc. | 4.69B | 0.61% | 348,201 | 1.34M |
| 159 | SHC | Sotera Health Company | 4.36B | -1.39% | 3,752,690 | 1.19B |
| 160 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.34B | -3.55% | 239,455 | 754.05M |
| 161 | LGND | Ligand Pharmaceuticals Incorporated | 4.30B | -1.97% | 84,927 | 274.48M |
| 162 | HNGE | Hinge Health, Inc. | 4.23B | 1.35% | 797,556 | 646.34M |
| 163 | CAI | Caris Life Sciences, Inc. | 4.19B | -2.69% | 3,404,532 | 907.29M |
| 164 | RDNT | RadNet, Inc. | 4.09B | -2.56% | 474,222 | 2.14B |
| 165 | NAMS | NewAmsterdam Pharma Company N.V. | 4.09B | -3.63% | 865,777 | 22.57M |
| 166 | MANE | Veradermics, Incorporated | 4.07B | -6.89% | 314,820 | - |
| 167 | TVTX | Travere Therapeutics, Inc. | 3.97B | -3.29% | 735,511 | 536.20M |
| 168 | BLLN | BillionToOne, Inc. | 3.89B | -3.90% | 880,189 | 354.54M |
| 169 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.88B | -4.06% | 703,653 | 18.07M |
| 170 | LIVN | LivaNova PLC | 3.86B | -2.01% | 326,730 | 1.43B |
| 171 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.81B | 0.02% | 1,844,283 | 596.96M |
| 172 | NVST | Envista Holdings Corporation | 3.81B | -1.82% | 2,730,502 | 2.81B |
| 173 | AMRX | Amneal Pharmaceuticals, Inc. | 3.81B | -2.37% | 855,806 | 3.05B |
| 174 | IRTC | iRhythm Holdings, Inc. | 3.77B | 0.51% | 512,856 | 787.85M |
| 175 | ORKA | Oruka Therapeutics, Inc. | 3.74B | -2.94% | 944,068 | - |
| 176 | MMSI | Merit Medical Systems, Inc. | 3.67B | -1.57% | 512,700 | 1.54B |
| 177 | ACAD | ACADIA Pharmaceuticals Inc. | 3.67B | -2.90% | 750,969 | 1.10B |
| 178 | TLX | Telix Pharmaceuticals Limited | 3.64B | -2.67% | 62,906 | 803.79M |
| 179 | EWTX | Edgewise Therapeutics, Inc. | 3.56B | -2.68% | 637,307 | - |
| 180 | VKTX | Viking Therapeutics, Inc. | 3.54B | -3.97% | 1,224,173 | - |
| 181 | WRBY | Warby Parker Inc. | 3.52B | -0.73% | 1,757,591 | 890.57M |
| 182 | OGN | Organon & Co. | 3.52B | 0.26% | 2,336,361 | 6.16B |
| 183 | WAY | Waystar Holding Corp. | 3.47B | -4.04% | 869,986 | 1.16B |
| 184 | DOCS | Doximity, Inc. | 3.45B | 3.78% | 10,002,260 | 644.86M |
| 185 | CON | Concentra Group Holdings Parent, Inc. | 3.31B | -1.30% | 381,460 | 2.23B |
| 186 | ALHC | Alignment Healthcare, Inc. | 3.26B | -4.77% | 3,611,945 | 4.26B |
| 187 | ERAS | Erasca, Inc. | 3.18B | -1.25% | 1,948,090 | - |
| 188 | BKD | Brookdale Senior Living Inc. | 3.09B | -2.01% | 3,068,771 | 3.00B |
| 189 | VCYT | Veracyte, Inc. | 3.08B | -0.80% | 595,445 | 541.74M |
| 190 | MMED | MiniMed Group, Inc. | 3.07B | -1.44% | 437,087 | 2.99B |
| 191 | OPCH | Option Care Health, Inc. | 3.06B | -2.21% | 1,766,207 | 5.67B |
| 192 | TWST | Twist Bioscience Corporation | 3.04B | -7.74% | 1,913,440 | 409.48M |
| 193 | TNGX | Tango Therapeutics, Inc. | 3.02B | -15.96% | 5,822,871 | 56.99M |
| 194 | RCUS | Arcus Biosciences, Inc. | 3.01B | -4.01% | 522,246 | 236.00M |
| 195 | NHC | National HealthCare Corporation | 3.01B | -2.60% | 44,894 | 1.53B |
| 196 | ITGR | Integer Holdings Corporation | 3.01B | -1.36% | 211,447 | 1.86B |
| 197 | ICUI | ICU Medical, Inc. | 2.99B | -2.79% | 217,543 | 2.16B |
| 198 | DNLI | Denali Therapeutics Inc. | 2.98B | -3.20% | 1,579,527 | - |
| 199 | LFST | LifeStance Health Group, Inc. | 2.95B | -3.68% | 2,254,960 | 1.49B |
| 200 | GMRS | GMR Solutions Inc. | 2.94B | -4.98% | 715,682 | 5.74B |
| 201 | ALMS | Alumis Inc. | 2.92B | -6.94% | 694,103 | 8.40M |
| 202 | PRVA | Privia Health Group, Inc. | 2.89B | -1.20% | 593,621 | 2.25B |
| 203 | SUPN | Supernus Pharmaceuticals, Inc. | 2.87B | -3.38% | 420,949 | 776.83M |
| 204 | DYN | Dyne Therapeutics, Inc. | 2.87B | -5.09% | 694,393 | - |
| 205 | BEAM | Beam Therapeutics Inc. | 2.79B | -5.18% | 1,422,454 | 164.01M |
| 206 | SLNO | Soleno Therapeutics, Inc. | 2.76B | 0.01% | 1,151,878 | 285.01M |
| 207 | GPCR | Structure Therapeutics Inc. | 2.76B | -2.59% | 357,812 | - |
| 208 | KLRA | Kailera Therapeutics, Inc. | 2.73B | -2.09% | 353,241 | - |
| 209 | ARQT | Arcutis Biotherapeutics, Inc. | 2.69B | -0.37% | 1,045,453 | 415.62M |
| 210 | TXG | 10x Genomics, Inc. | 2.68B | -1.86% | 1,824,334 | 638.78M |
| 211 | TARS | Tarsus Pharmaceuticals, Inc. | 2.67B | -4.63% | 380,497 | 535.08M |
| 212 | VERA | Vera Therapeutics, Inc. | 2.66B | -6.22% | 680,599 | - |
| 213 | HAE | Haemonetics Corporation | 2.64B | -0.58% | 542,582 | 1.33B |
| 214 | NBTX | Nanobiotix S.A. | 2.61B | -7.86% | 51,445 | 38.27M |
| 215 | GRAL | GRAIL, Inc. | 2.57B | -3.04% | 430,526 | 156.12M |
| 216 | IRON | Disc Medicine, Inc. | 2.55B | -4.22% | 574,728 | - |
| 217 | ELVN | Enliven Therapeutics, Inc. | 2.54B | -3.06% | 349,687 | - |
| 218 | IDYA | IDEAYA Biosciences, Inc. | 2.48B | -1.94% | 510,678 | 225.27M |
| 219 | CLDX | Celldex Therapeutics, Inc. | 2.47B | -3.17% | 437,710 | 865.00K |
| 220 | HTFL | HeartFlow, Inc. | 2.46B | -11.45% | 1,567,329 | 176.03M |
| 221 | RARE | Ultragenyx Pharmaceutical Inc. | 2.46B | -2.95% | 786,878 | 670.00M |
| 222 | RLAY | Relay Therapeutics, Inc. | 2.41B | -1.72% | 1,458,901 | 10.68M |
| 223 | ACHC | Acadia Healthcare Company, Inc. | 2.39B | -2.87% | 670,484 | 3.37B |
| 224 | IMNM | Immunome, Inc. | 2.37B | -4.86% | 831,471 | 4.02M |
| 225 | NKTR | Nektar Therapeutics | 2.37B | -5.44% | 904,485 | 55.63M |
| 226 | DFTX | Definium Therapeutics, Inc. | 2.33B | 0.16% | 836,911 | - |
| 227 | ZLAB | Zai Lab Limited | 2.33B | 1.97% | 734,297 | 453.28M |
| 228 | GRDN | Guardian Pharmacy Services, Inc. | 2.31B | 0.63% | 367,025 | 1.46B |
| 229 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.30B | -5.28% | 3,234,833 | 885.72M |
| 230 | KOD | Kodiak Sciences Inc. | 2.29B | -5.06% | 493,026 | - |
| 231 | MLYS | Mineralys Therapeutics, Inc. | 2.26B | 0.26% | 630,168 | - |
| 232 | LMAT | LeMaitre Vascular, Inc. | 2.23B | -1.99% | 116,497 | 256.28M |
| 233 | PBH | Prestige Consumer Healthcare Inc. | 2.22B | 2.20% | 1,417,906 | 1.09B |
| 234 | TYRA | Tyra Biosciences, Inc. | 2.21B | 1.86% | 666,393 | - |
| 235 | TMDX | TransMedics Group, Inc. | 2.18B | 1.82% | 779,705 | 635.89M |
| 236 | HCM | HUTCHMED (China) Limited | 2.17B | -1.22% | 11,963 | 548.51M |
| 237 | AXGN | Axogen, Inc. | 2.17B | -0.37% | 497,725 | 238.11M |
| 238 | ADPT | Adaptive Biotechnologies Corporation | 2.07B | -2.05% | 1,116,686 | 295.41M |
| 239 | SEM | Select Medical Holdings Corporation | 2.05B | 0.27% | 1,079,490 | 5.52B |
| 240 | GENB | Generate Biomedicines, Inc. | 2.04B | 3.43% | 379,335 | 30.30M |
| 241 | NVCR | NovoCure Limited | 2.03B | -2.66% | 701,851 | 674.41M |
| 242 | TRVI | Trevi Therapeutics, Inc. | 2.03B | -5.24% | 586,672 | - |
| 243 | BHC | Bausch Health Companies Inc. | 2.03B | -0.46% | 791,684 | 10.53B |
| 244 | XRAY | DENTSPLY SIRONA Inc. | 2.01B | -3.60% | 7,519,191 | 3.68B |
| 245 | OCUL | Ocular Therapeutix, Inc. | 2.00B | -3.63% | 1,682,976 | 52.04M |
| 246 | MESO | Mesoblast Limited | 1.98B | -0.73% | 129,675 | 65.38M |
| 247 | PHVS | Pharvaris N.V. | 1.97B | -1.79% | 327,490 | - |
| 248 | AUPH | Aurinia Pharmaceuticals Inc. | 1.97B | -3.41% | 729,705 | 298.30M |
| 249 | OMCL | Omnicell, Inc. | 1.95B | -1.87% | 255,266 | 1.23B |
| 250 | ESTA | Establishment Labs Holdings Inc. | 1.94B | -5.26% | 428,116 | 229.58M |
| 251 | ADMA | ADMA Biologics, Inc. | 1.92B | -2.59% | 2,242,719 | 509.86M |
| 252 | ASTH | Astrana Health, Inc. | 1.90B | -2.27% | 206,575 | 3.53B |
| 253 | AAPG | Ascentage Pharma Group International | 1.88B | -2.95% | 28,453 | 82.08M |
| 254 | STOK | Stoke Therapeutics, Inc. | 1.88B | -3.86% | 496,018 | 32.08M |
| 255 | NTLA | Intellia Therapeutics, Inc. | 1.88B | 2.64% | 9,408,578 | 66.09M |
| 256 | SRPT | Sarepta Therapeutics, Inc. | 1.86B | -5.51% | 1,881,657 | 2.18B |
| 257 | ANAB | AnaptysBio, Inc. | 1.84B | 1.83% | 256,487 | 232.39M |
| 258 | SION | Sionna Therapeutics, Inc. | 1.84B | -4.93% | 190,642 | - |
| 259 | LKFT | Lakefront Biotherapeutics NV | 1.83B | -1.42% | 120,286 | 1.20B |
| 260 | MD | Pediatrix Medical Group, Inc. | 1.82B | -3.28% | 448,124 | 1.93B |
| 261 | PGNY | Progyny, Inc. | 1.81B | 1.18% | 505,548 | 1.29B |
| 262 | SGRY | Surgery Partners, Inc. | 1.80B | -3.94% | 1,037,020 | 3.34B |
| 263 | SNDX | Syndax Pharmaceuticals, Inc. | 1.80B | -1.41% | 1,125,926 | 217.17M |
| 264 | CLOV | Clover Health Investments, Corp. | 1.79B | -2.72% | 8,947,766 | 2.21B |
| 265 | RAPP | Rapport Therapeutics, Inc. | 1.79B | -1.50% | 143,325 | 20.00M |
| 266 | NEOG | Neogen Corporation | 1.79B | -2.67% | 929,859 | 870.56M |
| 267 | OCS | Oculis Holding AG | 1.78B | -0.28% | 157,622 | 1.40M |
| 268 | SNDA | Sonida Senior Living, Inc. | 1.77B | -1.84% | 344,911 | 367.34M |
| 269 | HRMY | Harmony Biosciences Holdings, Inc. | 1.75B | -1.95% | 258,343 | 899.11M |
| 270 | VRDN | Viridian Therapeutics, Inc. | 1.74B | -3.33% | 1,137,294 | 70.92M |
| 271 | ZYME | Zymeworks Inc. | 1.74B | -0.75% | 425,054 | 81.26M |
| 272 | TSHA | Taysha Gene Therapies, Inc. | 1.71B | -5.40% | 2,081,932 | 7.47M |
| 273 | PLSE | Pulse Biosciences, Inc. | 1.70B | -9.34% | 438,690 | 751.00K |
| 274 | QURE | uniQure N.V. | 1.69B | -3.46% | 916,983 | 18.09M |
| 275 | VCEL | Vericel Corporation | 1.69B | -0.24% | 244,246 | 292.09M |
| 276 | AVAH | Aveanna Healthcare Holdings Inc. | 1.67B | 3.49% | 2,314,731 | 2.52B |
| 277 | AGIO | Agios Pharmaceuticals, Inc. | 1.67B | -2.12% | 316,487 | 66.05M |
| 278 | CAPR | Capricor Therapeutics, Inc. | 1.67B | -3.39% | 720,360 | 11.13M |
| 279 | UFPT | UFP Technologies, Inc. | 1.67B | -2.53% | 224,794 | 608.85M |
| 280 | ADUS | Addus HomeCare Corporation | 1.66B | -1.57% | 205,318 | 1.45B |
| 281 | ANIP | ANI Pharmaceuticals, Inc. | 1.66B | -1.87% | 210,218 | 923.71M |
| 282 | NRIX | Nurix Therapeutics, Inc. | 1.65B | -0.38% | 624,996 | 71.78M |
| 283 | PVLA | Palvella Therapeutics, Inc. | 1.65B | -3.57% | 198,090 | - |
| 284 | INBX | Inhibrx Biosciences, Inc. | 1.63B | -4.31% | 324,527 | 1.30M |
| 285 | INVA | Innoviva, Inc. | 1.62B | -3.76% | 570,499 | 420.69M |
| 286 | AHG | Akso Health Group | 1.62B | -7.35% | 84,473 | 14.84M |
| 287 | STAA | STAAR Surgical Company | 1.61B | 0.87% | 864,198 | 290.38M |
| 288 | PGEN | Precigen, Inc. | 1.59B | -2.83% | 2,563,547 | 31.60M |
| 289 | RXRX | Recursion Pharmaceuticals, Inc. | 1.57B | -2.63% | 13,089,784 | 66.41M |
| 290 | MBX | MBX Biosciences, Inc. | 1.55B | -7.72% | 464,125 | - |
| 291 | IOVA | Iovance Biotherapeutics, Inc. | 1.54B | -1.70% | 5,655,395 | 285.61M |
| 292 | ARDX | Ardelyx, Inc. | 1.54B | -3.56% | 2,428,096 | 427.68M |
| 293 | GLUE | Monte Rosa Therapeutics, Inc. | 1.53B | -2.84% | 679,983 | 42.95M |
| 294 | NUVB | Nuvation Bio Inc. | 1.52B | -7.42% | 5,564,448 | 143.05M |
| 295 | ALMR | Alamar Biosciences, Inc. | 1.51B | -3.29% | 191,513 | 74.21M |
| 296 | NVAX | Novavax, Inc. | 1.50B | -2.57% | 3,118,326 | 596.34M |
| 297 | DMRA | Damora Therapeutics, Inc. | 1.49B | 3.18% | 375,463 | - |
| 298 | PRCT | PROCEPT BioRobotics Corporation | 1.49B | -1.10% | 1,662,469 | 322.02M |
| 299 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.48B | -4.18% | 606,848 | -665.00K |
| 300 | VIR | Vir Biotechnology, Inc. | 1.48B | -3.63% | 1,246,664 | 65.50M |
| 301 | PRGO | Perrigo Company plc | 1.48B | -1.66% | 1,460,748 | 4.18B |
| 302 | ATAI | AtaiBeckley Inc. | 1.47B | -0.99% | 2,288,887 | 3.49M |
| 303 | HCSG | Healthcare Services Group, Inc. | 1.47B | -1.16% | 243,703 | 1.85B |
| 304 | ARDT | Ardent Health, Inc. | 1.46B | -1.16% | 344,214 | 6.43B |
| 305 | IMTX | Immatics N.V. | 1.44B | -3.58% | 236,009 | 43.00M |
| 306 | IMCR | Immunocore Holdings plc | 1.43B | -1.91% | 145,300 | 412.81M |
| 307 | ATRC | AtriCure, Inc. | 1.43B | - | 581,847 | 552.16M |
| 308 | KALV | KalVista Pharmaceuticals, Inc. | 1.42B | -0.07% | 7,643,701 | 114.48M |
| 309 | AHCO | AdaptHealth Corp. | 1.42B | -1.02% | 604,328 | 3.29B |
| 310 | MAZE | Maze Therapeutics, Inc. | 1.41B | -3.52% | 249,025 | 20.00M |
| 311 | CMPS | COMPASS Pathways plc | 1.41B | -1.79% | 2,689,901 | - |
| 312 | ENOV | Enovis Corporation | 1.41B | -6.51% | 798,173 | 2.28B |
| 313 | AGL | agilon health, inc. | 1.40B | 7.01% | 355,928 | 5.82B |
| 314 | URGN | UroGen Pharma Ltd. | 1.40B | -3.34% | 740,430 | 140.49M |
| 315 | PAHC | Phibro Animal Health Corporation | 1.39B | -4.95% | 241,994 | 1.50B |
| 316 | GHRS | GH Research PLC | 1.34B | -2.61% | 158,217 | - |
| 317 | BHVN | Biohaven Ltd. | 1.32B | -2.44% | 1,219,222 | - |
| 318 | BCAX | Bicara Therapeutics Inc. | 1.32B | -2.52% | 350,345 | - |
| 319 | SLS | SELLAS Life Sciences Group, Inc. | 1.32B | -4.65% | 7,343,223 | - |
| 320 | SVRA | Savara Inc. | 1.30B | -2.66% | 2,011,883 | - |
| 321 | WVE | Wave Life Sciences Ltd. | 1.30B | -2.17% | 2,947,169 | 71.80M |
| 322 | AVBP | ArriVent BioPharma, Inc. | 1.30B | -1.90% | 170,295 | - |
| 323 | MPLT | MapLight Therapeutics, Inc. | 1.30B | -2.36% | 128,210 | - |
| 324 | FTRE | Fortrea Holdings Inc. | 1.29B | -4.21% | 684,497 | 2.71B |
| 325 | MLTX | MoonLake Immunotherapeutics | 1.28B | -4.13% | 443,139 | - |
| 326 | ABCL | AbCellera Biologics Inc. | 1.26B | -6.48% | 7,849,827 | 79.21M |
| 327 | AVLN | Avalyn Pharma Inc. | 1.25B | -2.20% | 160,667 | - |
| 328 | COAG | Hemab Therapeutics Holdings, Inc. | 1.24B | -1.09% | 84,033 | - |
| 329 | PNTG | The Pennant Group, Inc. | 1.24B | -3.66% | 297,186 | 1.02B |
| 330 | SEPN | Septerna, Inc. | 1.22B | -4.10% | 403,453 | 72.26M |
| 331 | WGS | GeneDx Holdings Corp. | 1.21B | 4.53% | 1,341,465 | 442.68M |
| 332 | NNNN | Anbio Biotechnology | 1.20B | 8.90% | 18,567 | 8.65M |
| 333 | KMTS | Kestra Medical Technologies, Ltd. | 1.19B | -7.61% | 256,448 | 83.72M |
| 334 | OLMA | Olema Pharmaceuticals, Inc. | 1.19B | -1.45% | 869,857 | - |
| 335 | DBVT | DBV Technologies S.A. | 1.17B | -1.26% | 55,827 | 5.74M |
| 336 | INSP | Inspire Medical Systems, Inc. | 1.16B | -5.66% | 1,115,584 | 915.25M |
| 337 | ATEC | Alphatec Holdings, Inc. | 1.16B | -0.40% | 1,816,359 | 787.08M |
| 338 | ZBIO | Zenas BioPharma, Inc. | 1.16B | -2.91% | 453,293 | 10.00M |
| 339 | AVNS | Avanos Medical, Inc. | 1.16B | 0.06% | 291,614 | 715.90M |
| 340 | IVA | Inventiva S.A. | 1.16B | -1.17% | 236,555 | 7.94M |
| 341 | HROW | Harrow, Inc. | 1.16B | 0.45% | 903,222 | 268.68M |
| 342 | JBIO | Jade Biosciences, Inc. | 1.15B | -3.15% | 465,858 | - |
| 343 | TDOC | Teladoc Health, Inc. | 1.15B | -3.33% | 3,095,796 | 2.51B |
| 344 | AORT | Artivion, Inc. | 1.12B | 0.74% | 574,458 | 458.69M |
| 345 | AMN | AMN Healthcare Services, Inc. | 1.11B | -5.15% | 621,173 | 3.42B |
| 346 | IRMD | IRADIMED CORPORATION | 1.11B | -0.23% | 101,414 | 86.28M |
| 347 | IART | Integra LifeSciences Holdings Corporation | 1.10B | -2.69% | 523,267 | 1.64B |
| 348 | COLL | Collegium Pharmaceutical, Inc. | 1.09B | -3.53% | 162,227 | 796.33M |
| 349 | XERS | Xeris Biopharma Holdings, Inc. | 1.09B | -1.41% | 938,911 | 314.85M |
| 350 | AKTS | Aktis Oncology, Inc. | 1.08B | 0.21% | 90,240 | 8.28M |
| 351 | NEO | NeoGenomics, Inc. | 1.08B | -0.84% | 635,965 | 745.97M |
| 352 | CNMD | CONMED Corporation | 1.07B | -2.24% | 246,551 | 1.37B |
| 353 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.07B | -3.85% | 1,120,945 | 204.73M |
| 354 | ALVO | Alvotech | 1.05B | -2.62% | 586,100 | 562.04M |
| 355 | EYPT | EyePoint, Inc. | 1.04B | -6.12% | 370,552 | 7.61M |
| 356 | CDNA | CareDx, Inc. | 1.03B | -2.39% | 381,161 | 412.82M |
| 357 | CRVS | Corvus Pharmaceuticals, Inc. | 1.03B | -10.36% | 2,701,141 | - |
| 358 | CRON | Cronos Group Inc. | 1.03B | -4.01% | 3,350,620 | 159.54M |
| 359 | BFLY | Butterfly Network, Inc. | 1.00B | -6.59% | 3,137,026 | 102.92M |
| 360 | OMDA | Omada Health, Inc. | 998.73M | 1.33% | 906,863 | 283.30M |
| 361 | LXRX | Lexicon Pharmaceuticals, Inc. | 997.01M | -3.65% | 1,759,700 | 69.64M |
| 362 | BLFS | BioLife Solutions, Inc. | 994.25M | -3.37% | 173,035 | 101.66M |
| 363 | EVO | Evotec SE | 975.16M | -1.65% | 40,265 | 859.03M |
| 364 | INNV | InnovAge Holding Corp. | 967.80M | -4.04% | 135,625 | 949.17M |
| 365 | CGEM | Cullinan Therapeutics, Inc. | 964.89M | -2.79% | 413,739 | - |
| 366 | USPH | U.S. Physical Therapy, Inc. | 961.22M | -2.97% | 230,179 | 787.69M |
| 367 | PHAT | Phathom Pharmaceuticals, Inc. | 954.75M | -7.89% | 687,748 | 204.89M |
| 368 | MNKD | MannKind Corporation | 950.02M | -4.50% | 3,383,629 | 360.78M |
| 369 | PHAR | Pharming Group N.V. | 929.08M | -0.62% | 4,245 | 369.49M |
| 370 | DRTS | Alpha Tau Medical Ltd. | 917.94M | 0.19% | 795,171 | - |
| 371 | PCRX | Pacira BioSciences, Inc. | 899.89M | -2.80% | 310,038 | 734.86M |
| 372 | SPTX | Seaport Therapeutics, Inc. | 895.11M | -0.35% | 554,592 | - |
| 373 | SDGR | Schrödinger, Inc. | 892.91M | -5.31% | 772,460 | 254.91M |
| 374 | BVS | Bioventus Inc. | 891.32M | 0.57% | 404,468 | 576.30M |
| 375 | DSGN | Design Therapeutics, Inc. | 886.89M | -2.34% | 289,653 | - |
| 376 | OMER | Omeros Corporation | 885.87M | -7.83% | 2,749,256 | 9.89M |
| 377 | INMD | InMode Ltd. | 881.95M | -0.93% | 640,293 | 374.64M |
| 378 | MGTX | MeiraGTx Holdings plc | 881.64M | -4.32% | 480,197 | 79.76M |
| 379 | TALK | Talkspace, Inc. | 869.39M | - | 1,038,762 | 238.37M |
| 380 | TNDM | Tandem Diabetes Care, Inc. | 860.73M | -11.24% | 4,988,958 | 1.03B |
| 381 | SANA | Sana Biotechnology, Inc. | 859.92M | -1.59% | 2,575,352 | - |
| 382 | NUTX | Nutex Health Inc. | 856.25M | -2.67% | 59,392 | 879.95M |
| 383 | LBRX | LB Pharmaceuticals Inc | 855.28M | -5.05% | 151,783 | - |
| 384 | ANNX | Annexon, Inc. | 855.26M | -2.79% | 1,164,820 | - |
| 385 | ORIC | ORIC Pharmaceuticals, Inc. | 849.88M | -1.56% | 673,225 | - |
| 386 | JANX | Janux Therapeutics, Inc. | 844.63M | -3.75% | 493,769 | 13.73M |
| 387 | TBPH | Theravance Biopharma, Inc. | 844.44M | -0.79% | 330,810 | 109.78M |
| 388 | XNCR | Xencor, Inc. | 843.73M | -4.21% | 581,141 | 97.36M |
| 389 | ABUS | Arbutus Biopharma Corporation | 839.54M | -2.30% | 966,901 | 191.45M |
| 390 | OPK | OPKO Health, Inc. | 838.15M | 0.91% | 2,016,033 | 581.12M |
| 391 | GERN | Geron Corporation | 837.18M | -6.79% | 13,088,338 | 196.12M |
| 392 | ODTX | Odyssey Therapeutics, Inc. | 832.15M | 1.85% | 352,570 | 2.98M |
| 393 | GDRX | GoodRx Holdings, Inc. | 831.45M | -1.41% | 1,091,399 | 787.89M |
| 394 | KURA | Kura Oncology, Inc. | 820.28M | -5.13% | 1,088,973 | 71.64M |
| 395 | EVMN | Evommune, Inc. | 820.14M | 0.22% | 375,313 | 10.00M |
| 396 | ETON | Eton Pharmaceuticals, Inc. | 817.11M | -0.43% | 399,606 | 86.93M |
| 397 | ANRO | Alto Neuroscience, Inc. | 810.07M | -2.03% | 309,460 | - |
| 398 | ESPR | Esperion Therapeutics, Inc. | 804.47M | 0.16% | 6,857,720 | 418.24M |
| 399 | ABSI | Absci Corporation | 801.35M | -7.22% | 2,849,607 | 1.84M |
| 400 | AURA | Aura Biosciences, Inc. | 799.70M | -3.07% | 355,073 | - |
| 401 | VOR | Vor Biopharma Inc. | 794.36M | -2.72% | 468,925 | - |
| 402 | CTMX | CytomX Therapeutics, Inc. | 788.08M | -4.23% | 1,981,831 | 35.54M |
| 403 | BIOA | BioAge Labs, Inc. | 780.15M | -6.22% | 266,142 | 10.32M |
| 404 | SGP | SpyGlass Pharma, Inc. | 775.16M | -4.45% | 26,368 | - |
| 405 | SSII | SS Innovations International, Inc. | 765.77M | -4.01% | 38,058 | 48.47M |
| 406 | DRUG | Bright Minds Biosciences Inc. | 763.26M | -1.85% | 244,016 | - |
| 407 | AMPH | Amphastar Pharmaceuticals, Inc. | 746.49M | -2.14% | 519,714 | 720.53M |
| 408 | AZTA | Azenta, Inc. | 742.09M | -4.17% | 1,010,135 | 596.48M |
| 409 | SPRY | ARS Pharmaceuticals, Inc. | 733.83M | -6.93% | 3,040,910 | 84.28M |
| 410 | RLMD | Relmada Therapeutics, Inc. | 730.55M | -6.13% | 1,164,817 | - |
| 411 | EIKN | Eikon Therapeutics, Inc. | 719.50M | 0.83% | 276,633 | - |
| 412 | QDEL | QuidelOrtho Corporation | 719.41M | -7.37% | 1,684,802 | 2.66B |
| 413 | EHAB | Enhabit, Inc. | 706.91M | - | - | 1.06B |
| 414 | TENX | Tenax Therapeutics, Inc. | 697.71M | -0.42% | 582,984 | - |
| 415 | CERT | Certara, Inc. | 696.15M | -2.93% | 1,761,703 | 419.75M |
| 416 | ALLO | Allogene Therapeutics, Inc. | 693.76M | -6.07% | 5,849,469 | 22.00K |
| 417 | SLDB | Solid Biosciences Inc. | 679.30M | -9.57% | 1,511,580 | - |
| 418 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 674.68M | -0.94% | 573,012 | - |
| 419 | PSNL | Personalis, Inc. | 670.22M | -4.62% | 1,269,401 | 64.52M |
| 420 | LMRI | Lumexa Imaging Holdings, Inc. | 670.16M | -3.26% | 1,649,346 | 1.03B |
| 421 | BWAY | BrainsWay Ltd. | 665.08M | -6.92% | 206,617 | 56.22M |
| 422 | CBIO | Crescent Biopharma, Inc. | 663.58M | -5.93% | 216,306 | 11.88M |
| 423 | HSTM | HealthStream, Inc. | 659.39M | -0.97% | 144,604 | 311.78M |
| 424 | ZVRA | Zevra Therapeutics, Inc. | 654.40M | -5.06% | 1,340,058 | 122.29M |
| 425 | STRO | Sutro Biopharma, Inc. | 651.78M | 2.39% | 212,471 | 102.48M |
| 426 | CADL | Candel Therapeutics, Inc. | 646.24M | -1.01% | 3,280,485 | - |
| 427 | ACRS | Aclaris Therapeutics, Inc. | 638.26M | -4.79% | 660,424 | 8.37M |
| 428 | TLRY | Tilray Brands, Inc. | 632.80M | -3.55% | 3,435,862 | 858.28M |
| 429 | SIBN | SI-BONE, Inc. | 629.32M | -2.81% | 501,950 | 206.22M |
| 430 | AVR | Anteris Technologies Global Corp. | 628.60M | -0.14% | 805,612 | 1.85M |
| 431 | CBLL | CeriBell, Inc. | 623.78M | -0.12% | 255,285 | 95.07M |
| 432 | GYRE | Gyre Therapeutics, Inc. | 605.80M | -5.29% | 76,578 | 117.05M |
| 433 | TRAX | First Tracks Biotherapeutics, Inc. | 593.16M | -6.00% | 127,568 | - |
| 434 | CRMD | CorMedix Inc. | 591.53M | -4.92% | 2,234,883 | 400.05M |
| 435 | IRWD | Ironwood Pharmaceuticals, Inc. | 588.49M | -2.59% | 1,486,208 | 361.51M |
| 436 | ARVN | Arvinas, Inc. | 586.82M | -3.45% | 633,389 | 89.40M |
| 437 | KYTX | Kyverna Therapeutics, Inc. | 584.12M | -10.15% | 984,674 | - |
| 438 | CSTL | Castle Biosciences, Inc. | 581.73M | 1.59% | 345,244 | 339.92M |
| 439 | FBRX | Forte Biosciences, Inc. | 569.11M | -6.34% | 120,115 | - |
| 440 | VALN | Valneva SE | 567.81M | -3.64% | 24,941 | 180.25M |
| 441 | ALT | Altimmune, Inc. | 556.20M | -2.05% | 1,685,303 | 36.00K |
| 442 | ANL | Adlai Nortye Ltd. | 546.80M | -1.37% | 71,034 | 5.00M |
| 443 | CABA | Cabaletta Bio, Inc. | 542.14M | -7.89% | 2,571,529 | - |
| 444 | RIGL | Rigel Pharmaceuticals, Inc. | 540.26M | -8.52% | 355,307 | 299.77M |
| 445 | PRME | Prime Medicine, Inc. | 537.34M | -4.95% | 2,361,039 | 4.03M |
| 446 | PHR | Phreesia, Inc. | 533.50M | 0.11% | 1,014,217 | 480.59M |
| 447 | MDXG | MiMedx Group, Inc. | 532.48M | 0.70% | 779,445 | 389.42M |
| 448 | TECX | Tectonic Therapeutic, Inc. | 531.54M | -5.47% | 210,407 | - |
| 449 | AQST | Aquestive Therapeutics, Inc. | 529.40M | -10.78% | 2,956,126 | 50.27M |
| 450 | IMMX | Immix Biopharma, Inc. | 529.06M | -1.19% | 466,644 | - |
| 451 | XOMA | XOMA Royalty Corporation | 522.90M | -0.73% | 80,305 | 48.56M |
| 452 | AGMB | AgomAb Therapeutics NV | 518.09M | -4.71% | 37,899 | - |
| 453 | CLYM | Climb Bio, Inc. | 517.33M | -4.41% | 527,252 | - |
| 454 | NPCE | NeuroPace, Inc. | 514.30M | -4.46% | 62,099 | 99.53M |
| 455 | CTNM | Contineum Therapeutics, Inc. | 510.70M | -3.87% | 116,598 | - |
| 456 | TCMD | Tactile Systems Technology, Inc. | 510.67M | -1.74% | 180,784 | 343.52M |
| 457 | PRTA | Prothena Corporation plc | 509.40M | -1.32% | 434,399 | 57.94M |
| 458 | PROK | ProKidney Corp. | 507.29M | -1.75% | 772,708 | 893.00K |
| 459 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 460 | DNA | Ginkgo Bioworks Holdings, Inc. | 503.00M | -1.91% | 688,881 | 151.40M |
| 461 | UPB | Upstream Bio, Inc. | 492.50M | 2.96% | 769,088 | 3.32M |
| 462 | OFIX | Orthofix Medical Inc. | 485.46M | -2.28% | 133,319 | 825.37M |
| 463 | FDMT | 4D Molecular Therapeutics, Inc. | 482.51M | -5.91% | 377,585 | 88.24M |
| 464 | NGNE | Neurogene Inc. | 475.40M | -3.79% | 61,221 | 925.00K |
| 465 | STTK | Shattuck Labs, Inc. | 473.90M | -6.00% | 209,254 | 1.00M |
| 466 | CERS | Cerus Corporation | 472.87M | -5.98% | 2,205,446 | 216.56M |
| 467 | AVTX | Avalo Therapeutics, Inc. | 470.97M | -7.26% | 1,105,825 | 59.00K |
| 468 | OCGN | Ocugen, Inc. | 468.84M | -5.14% | 3,808,606 | 4.47M |
| 469 | KMDA | Kamada Ltd. | 465.11M | -3.30% | 51,319 | 180.46M |
| 470 | ASMB | Assembly Biosciences, Inc. | 456.75M | -5.15% | 95,383 | 71.10M |
| 471 | KIDS | OrthoPediatrics Corp. | 456.29M | -0.75% | 92,313 | 243.30M |
| 472 | OVID | Ovid Therapeutics Inc. | 455.95M | -5.89% | 991,012 | 7.12M |
| 473 | SRTA | Strata Critical Medical, Inc. | 455.13M | -3.84% | 779,941 | 228.58M |
| 474 | ANGO | AngioDynamics, Inc. | 452.25M | -1.63% | 179,405 | 313.73M |
| 475 | PRLD | Prelude Therapeutics Incorporated | 451.60M | 0.45% | 376,240 | 16.72M |
| 476 | FLGT | Fulgent Genetics, Inc. | 447.59M | -2.66% | 304,195 | 320.35M |
| 477 | FULC | Fulcrum Therapeutics, Inc. | 445.78M | -5.91% | 273,080 | 80.00M |
| 478 | CTKB | Cytek Biosciences, Inc. | 445.54M | 2.83% | 1,274,851 | 204.17M |
| 479 | EPRX | Eupraxia Pharmaceuticals Inc. | 444.71M | -3.07% | 156,976 | - |
| 480 | EVH | Evolent Health, Inc. | 444.30M | -3.66% | 2,135,959 | 1.89B |
| 481 | PRTC | PureTech Health plc | 442.35M | -1.89% | 4,308 | 4.66M |
| 482 | ZURA | Zura Bio Limited | 442.14M | -3.52% | 339,591 | - |
| 483 | VTVT | vTv Therapeutics Inc. | 440.79M | -7.57% | 43,558 | 36.84M |
| 484 | REPL | Replimune Group, Inc. | 440.52M | 8.22% | 4,722,176 | - |
| 485 | CATX | Perspective Therapeutics, Inc. | 436.80M | -0.78% | 616,161 | 618.00K |
| 486 | EOLS | Evolus, Inc. | 431.68M | -0.38% | 395,802 | 301.79M |
| 487 | SGMT | Sagimet Biosciences Inc. | 427.94M | -5.97% | 602,962 | - |
| 488 | AUTL | Autolus Therapeutics plc | 427.16M | 0.94% | 1,245,459 | 75.39M |
| 489 | CCRN | Cross Country Healthcare, Inc. | 424.85M | 0.08% | 385,812 | 1.00B |
| 490 | WEAV | Weave Communications, Inc. | 422.10M | 3.01% | 655,611 | 248.72M |
| 491 | IPSC | Century Therapeutics, Inc. | 421.13M | -1.89% | 625,947 | 109.16M |
| 492 | NRC | NRC Health | 418.73M | -1.85% | 87,765 | 138.64M |
| 493 | ADCT | ADC Therapeutics SA | 415.92M | -2.68% | 738,600 | 79.18M |
| 494 | LYEL | Lyell Immunopharma, Inc. | 414.15M | -6.68% | 89,430 | 31.00K |
| 495 | BBNX | Beta Bionics, Inc. | 413.53M | 0.87% | 532,761 | 110.24M |
| 496 | EBS | Emergent BioSolutions Inc. | 412.25M | -2.68% | 307,552 | 676.80M |
| 497 | VREX | Varex Imaging Corporation | 412.19M | -2.40% | 406,001 | 857.50M |
| 498 | CGC | Canopy Growth Corporation | 410.40M | -4.21% | 6,412,212 | 203.04M |
| 499 | TOI | The Oncology Institute, Inc. | 395.93M | -1.98% | 758,258 | 545.76M |
| 500 | LXEO | Lexeo Therapeutics, Inc. | 395.75M | -8.36% | 446,367 | - |